BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1839224)

  • 1. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner.
    Edelberg JM; Pizzo SV
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):759-64. PubMed ID: 1839224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) in the regulation of fibrinolysis.
    Edelberg JM; Pizzo SV
    J Atheroscler Thromb; 1995; 2 Suppl 1():S5-7. PubMed ID: 9225222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein(a): a link between thrombogenesis and atherogenesis].
    Vucković B; Derić M
    Med Pregl; 2007; 60(1-2):37-41. PubMed ID: 17853709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a), fibrin binding, and plasminogen activation.
    Loscalzo J; Weinfeld M; Fless GM; Scanu AM
    Arteriosclerosis; 1990; 10(2):240-5. PubMed ID: 2138452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) regulates plasmin generation and inhibition.
    Edelberg J; Pizzo SV
    Chem Phys Lipids; 1994 Jan; 67-68():363-8. PubMed ID: 8187236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
    Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation.
    Edelberg JM; Pizzo SV
    Biochemistry; 1990 Jun; 29(25):5906-11. PubMed ID: 2143417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM; Reilly CF; Pizzo SV
    J Biol Chem; 1991 Apr; 266(12):7488-93. PubMed ID: 1708387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
    Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
    Simon DI; Fless GM; Scanu AM; Loscalzo J
    Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
    Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
    Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
    Aznar J; Estellés A; Bretó M; España F; Alós T
    Thromb Res; 1992 Jun; 66(5):569-82. PubMed ID: 1387993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN; Harpel PC; Pannell R; Gurewich V
    Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) enhances plasma clot lysis in vitro.
    Mao SJ; Tucci MA
    FEBS Lett; 1990 Jul; 267(1):131-4. PubMed ID: 2142106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential basis for the thrombotic risks associated with lipoprotein(a).
    Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
    Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
    Feric NT; Boffa MB; Johnston SM; Koschinsky ML
    J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
    Armstrong VW
    Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
    Marcovina SM; Koschinsky ML
    Curr Opin Lipidol; 2003 Aug; 14(4):361-6. PubMed ID: 12865733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.